Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDL PROTECT: Atorvastatin in Type 2 Diabetes
NCT02125682Phase 4Completed
- Sponsor
- Hôtel-Dieu de France
- Start
- Jan 2012
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in dyslipidemia, sponsored by Hôtel-Dieu de France. Started Jan 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02125682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125682.